Autopsy report · NCT03724409

Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases

“Pandemic”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 years 7 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Early Phase 1

Sponsor

Sandeep Laroia

Sponsor type

University, hospital or other

Conditions

Neuroendocrine Tumors

Interventions

[90]Y-DOTATOC

Participants

3

Sites

1

Countries

United States

Trials that died the same way

• Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users
  “Global pandemic” (89% match in meaning)
• Resting Energy Expenditure in Patients With OHS Treated With Long-term NIV
  “COVID pandemic” (84% match in meaning)
• Brief-Illness Perception Questionnaire (Brief-IPQ) Used in Patients With Chronic Non-malignant Pain.
  “Corona pandemic” (79% match in meaning)
• Efficacy of Aspirin and L-arginine in High Risk Preeclamptic
  “COVID-19 pandemic” (75% match in meaning)
• Early Kangaroo Mother Care in Gambian Hospitalised Unstable Neonates
  “In response to COVID pandemic” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.